Stockholders’ Equity |
6 Months Ended |
|---|---|
Jun. 27, 2026 | |
| Equity [Abstract] | |
| Stockholders’ Equity | 14. Stockholders’ Equity Preferred Stock The Company’s Second Restated Certificate of Incorporation authorizes the Company to issue up to 100,000,000 shares of preferred stock, $0.001 value per share, all of which is undesignated. Common Stock The Company’s Second Restated Certificate of Incorporation authorizes the Company to issue up to 750,000,000 shares of Common Stock, $0.001 value per share. Each share of Common Stock is entitled to one vote on all matters submitted to a vote of the Company’s stockholders. The holders of Common Stock are entitled to receive dividends, if any, as may be declared by the Board of Directors. Dividends paid For the three and six months ended June 27, 2026 and June 28, 2025, no dividends were declared or paid to the Company’s common stockholders. Share Repurchase Program On July 28, 2025, the Board of Directors authorized the Company’s share repurchase program (the “Share Repurchase Program”) such that the Company is authorized to repurchase from time to time up to an aggregate of $450 million of its outstanding shares of Common Stock, which authorization expires on July 28, 2028. During the three months ended June 27, 2026, the Company repurchased approximately 4.1 million shares of Common Stock in the open market at an average price per share of $14.24, for an aggregate consideration of approximately $58.0 million, as part of the Share Repurchase Program. For the six months ended June 27, 2026, the Company repurchased approximately 4.4 million shares of Common Stock in the open market at an average price per share of $14.43, for an aggregate consideration of approximately $63.8 million, as part of the Share Repurchase Program. As of June 27, 2026, $382.3 million remained available for additional share repurchases under the program. The Company had no repurchases during the three or six months ended June 28, 2025 under the previous share repurchase authorization
|